UNSPSC 51141551: Ciprazafone

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8RSD11181G. European Medicines Agency schedules Ciprazafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07466MIG. Ciprazafone generally arises in the molecular formula C19H18CL2N2O2. The term CIPRAZAFONE is an International Non-Proprietary Name or INN. CIPRAZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule ciprazafone under HS 29242995 and SITC 51479. As of Q4 2014, CIPRAZAFONE remains the US FDA Preferred Term for this commodity. Ciprazafone bears US NLM identifiers UMLS ID C2699233 and NCI Concept Code C78000. SMILES: CLC1CC(C(N(C(=O)CNC2CC2)C)CC1)C(=O)C1C(CL)CCCC1.

UNSPSC 51141551 Ciprazafone is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with a due date of July 26, 2023 — solicits Naloxone and Safe Drug Deactivation Systems, not ciprazafone. The mismatch suggests either a tagging error in the source data or a divergence between the code's nominal pharmaceutical scope and actual buying practice in this jurisdiction. The Seminole County procurement is for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option.

The code shows minimal recent activity under its stated scope, with no additional state or local opportunities recorded beyond the Seminole County award. The single opportunity demonstrates that when activity does occur, county health and community services departments are the issuing bodies, and the work involves pharmaceutical procurement tied to public health initiatives — in this case, opioid overdose response. Without additional opportunities in the dataset, no meaningful geographic concentration or issuing-body pattern can be characterized. Bidders on the Seminole County IFB must comply with drug-free workplace certification, E-Verify requirements, and federal regulations potentially tied to FEMA funding. The procurement does not specify set-aside designations for disadvantaged enterprises.